Jeff Johnson
Stock Analyst at Baird
(4.68)
# 178
Out of 5,149 analysts
154
Total ratings
60%
Success rate
29.26%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Upgrades: Outperform | $78 → $100 | $80.21 | +24.67% | 11 | Feb 23, 2026 | |
| BBNX Beta Bionics | Maintains: Neutral | $28 → $14 | $11.57 | +21.00% | 3 | Feb 18, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $18 → $30 | $23.74 | +26.37% | 17 | Dec 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $117 → $100 | $97.97 | +2.07% | 15 | Dec 16, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $85 → $98 | $83.37 | +17.55% | 19 | Dec 5, 2025 | |
| ALC Alcon | Maintains: Outperform | $95 → $98 | $83.08 | +17.96% | 11 | Nov 13, 2025 | |
| DXCM DexCom | Maintains: Outperform | $112 → $90 | $73.08 | +23.15% | 15 | Sep 26, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $28.67 | -19.78% | 10 | May 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $384.59 | +5.31% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $182.64 | +51.12% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $241.84 | -1.59% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $25.29 | +176.79% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $13.60 | +348.53% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $13.30 | +403.76% | 6 | Feb 18, 2022 |
Henry Schein
Feb 23, 2026
Upgrades: Outperform
Price Target: $78 → $100
Current: $80.21
Upside: +24.67%
Beta Bionics
Feb 18, 2026
Maintains: Neutral
Price Target: $28 → $14
Current: $11.57
Upside: +21.00%
Tandem Diabetes Care
Dec 16, 2025
Upgrades: Outperform
Price Target: $18 → $30
Current: $23.74
Upside: +26.37%
Zimmer Biomet Holdings
Dec 16, 2025
Downgrades: Neutral
Price Target: $117 → $100
Current: $97.97
Upside: +2.07%
The Cooper Companies
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $98
Current: $83.37
Upside: +17.55%
Alcon
Nov 13, 2025
Maintains: Outperform
Price Target: $95 → $98
Current: $83.08
Upside: +17.96%
DexCom
Sep 26, 2025
Maintains: Outperform
Price Target: $112 → $90
Current: $73.08
Upside: +23.15%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $28.67
Upside: -19.78%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $384.59
Upside: +5.31%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $182.64
Upside: +51.12%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $241.84
Upside: -1.59%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $25.29
Upside: +176.79%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $13.60
Upside: +348.53%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $13.30
Upside: +403.76%